Dong S, Wang M, Luo Z, Wu W, Huang H, Yang J, Liang Y, Jiang H, Qiu L. Glofitamab plus polatuzumab vedotin: a novel safe, and highly effective chemotherapy-free regimen for pediatric relapsed/refractory B-cell non-Hodgkin lymphoma. Haematologica; https://doi.org/10.3324/haematol.2026.300836 [Early view].